These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 22654506)

  • 1. Requirements for acquiring a high-quality house dust mite extract for allergen immunotherapy.
    Frati F; Incorvaia C; David M; Scurati S; Seta S; Padua G; Cattaneo E; Cavaliere C; Di Rienzo A; Dell'Albani I; Puccinelli P
    Drug Des Devel Ther; 2012; 6():117-23. PubMed ID: 22654506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention Is Better than Cure: Impact of Allergen Immunotherapy on the Progression of Airway Disease.
    Arshad H; Lack G; Durham SR; Penagos M; Larenas-Linnemann D; Halken S
    J Allergy Clin Immunol Pract; 2024 Jan; 12(1):45-56. PubMed ID: 37844847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allergen immunotherapy for house dust mite: clinical efficacy and immunological mechanisms in allergic rhinitis and asthma.
    Eifan AO; Calderon MA; Durham SR
    Expert Opin Biol Ther; 2013 Nov; 13(11):1543-56. PubMed ID: 24099116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
    Calderon MA; Casale TB; Nelson HS; Demoly P
    J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. House dust mite sublingual immunotherapy: a double-blind, placebo-controlled study in elderly patients with allergic rhinitis.
    Bozek A; Ignasiak B; Filipowska B; Jarzab J
    Clin Exp Allergy; 2013 Feb; 43(2):242-8. PubMed ID: 23331565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A milestone in house dust-mite-allergen immunotherapy: the new sublingual tablet S-524101 (actair).
    Bahceciler NN; Babayigit Hocaoglu A; Galip N
    Expert Rev Vaccines; 2014 Dec; 13(12):1427-38. PubMed ID: 25345538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis.
    Bergmann KC; Demoly P; Worm M; Fokkens WJ; Carrillo T; Tabar AI; Nguyen H; Montagut A; Zeldin RK
    J Allergy Clin Immunol; 2014 Jun; 133(6):1608-14.e6. PubMed ID: 24388010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sublingual immunotherapy for allergic rhinitis.
    Wilson DR; Torres LI; Durham SR
    Cochrane Database Syst Rev; 2003; (2):CD002893. PubMed ID: 12804442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
    Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
    Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of the efficacy of specific immunotherapy with house-dust mite extracts in adults with allergic rhinitis and/or asthma].
    Polzehl D; Keck T; Riechelmann H
    Laryngorhinootologie; 2003 Apr; 82(4):272-80. PubMed ID: 12717603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis.
    Wilson DR; Lima MT; Durham SR
    Allergy; 2005 Jan; 60(1):4-12. PubMed ID: 15575924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical management and sublingual immunotherapy practices in patients with house dust mite-induced respiratory allergy: a retrospective, observational study.
    Trebuchon F; David M; Demoly P
    Int J Immunopathol Pharmacol; 2012; 25(1):193-206. PubMed ID: 22507332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized double-blind placebo-controlled trial of sublingual immunotherapy in children with house dust mite allergy in primary care: study design and recruitment.
    de Bot CM; Moed H; Berger MY; Röder E; de Groot H; de Jongste JC; van Wijk RG; van der Wouden JC
    BMC Fam Pract; 2008 Oct; 9():59. PubMed ID: 18937864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
    Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
    Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: a randomized, double-blind, placebo-controlled trial.
    Mosbech H; Deckelmann R; de Blay F; Pastorello EA; Trebas-Pietras E; Andres LP; Malcus I; Ljørring C; Canonica GW
    J Allergy Clin Immunol; 2014 Sep; 134(3):568-575.e7. PubMed ID: 24797423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sublingual immunotherapy with house dust extract for house dust-mite allergic rhinitis in children.
    Yonekura S; Okamoto Y; Sakurai D; Horiguchi S; Hanazawa T; Nakano A; Kudou F; Nakamaru Y; Honda K; Hoshioka A; Shimojo N; Kohno Y
    Allergol Int; 2010 Dec; 59(4):381-8. PubMed ID: 20864799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sublingual immunotherapy to house dust mite in pediatric patients with allergic rhinitis and asthma: a retrospective analysis of clinical course over a 3-year follow-up period.
    Nuhoglu Y; Ozumut SS; Ozdemir C; Ozdemir M; Nuhoglu C; Erguven M
    J Investig Allergol Clin Immunol; 2007; 17(6):375-8. PubMed ID: 18088019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. House dust mite-specific immunotherapy alters the natural course of atopic march.
    Tang RB
    J Chin Med Assoc; 2020 Feb; 83(2):109-112. PubMed ID: 32015265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of a glutaraldehyde-modified house dust mite extract in allergic rhinitis.
    Riechelmann H; Schmutzhard J; van der Werf JF; Distler A; Kleinjans HA
    Am J Rhinol Allergy; 2010; 24(5):e104-9. PubMed ID: 21244725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. House Dust Mite Sublingual Immunotherapy for Pediatric Patients With Allergic Asthma.
    Richards JR; Stumpf JL
    Ann Pharmacother; 2018 Oct; 52(10):1019-1030. PubMed ID: 29642713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.